Medication trials in an imperfect world: gout and Parkinson's disease.
Friedman
Joseph H
JH
D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D002986:Clinical Trials as Topic / Q000592:standards*; D018450:Disease Progression; D064420:Drug-Related Side Effects and Adverse Reactions; D006073:Gout / Q000139:chemically induced*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D014481:United States; D014486:United States Food and Drug Administration; D014527:Uric Acid / Q000378:metabolism
D000978:Antiparkinson Agents; D014527:Uric Acid